Navigation Links
VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009
Date:11/4/2009

al results to differ materially from current expectations include, but are not limited to:

  • our ability to comply with the NASDAQ rules for continued listing in order to maintain the listing of our common stock on NASDAQ;
  • our ability to obtain necessary financing in the near term, including amounts necessary to repay the loan from Bay City Capital by the December 31, 2009 maturity date (or earlier if certain repayment acceleration provisions are triggered);
  • our ability to control our operating expenses;
  • our ability to comply with covenants included in the loan from Bay City Capital;
  • our ability to timely recruit and enroll patients in any future clinical trials;
  • our failure to obtain sufficient data from enrolled patients that can be used to evaluate VIA-2291, thereby impairing the validity or statistical significance of our clinical trials;
  • our ability to successfully complete our clinical trials of VIA-2291 on expected timetables and the outcomes of such clinical trials;
  • complexities in designing and implementing cardiometabolic clinical trials using surrogate endpoints in Phase 1 and Phase 2 clinical trials which may differ from the ultimate endpoints required for registration of a candidate drug;
  • the results of our clinical trials, including without limitation, with respect to the safety and efficacy of VIA-2291;
  • if the results of the ACS and CEA studies, upon further review and analysis, are revised, interpreted differently by regulatory authorities or negated by later stage clinical trials;
  • our ability to obtain necessary FDA approvals, including to initiate future clinical trials of VIA-2291;
  • our ability to successfully commercialize VIA-2291;
  • our ability to identify potential clinical candidates from the family of DGAT1 compounds licensed and move them into preclinical development;
  • our ability to obtain and protect our intellectual prope
    '/>"/>

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Reportlinker Adds Gastrointestinal Pharmaceuticals: Technologies and Markets
2. Peregrine Pharmaceuticals Regains Full Compliance With Nasdaq Continued Listing Requirements
3. Isis Pharmaceuticals to Present at the 2009 Canaccord Adams Cardiovascular Conference
4. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
5. Quark Pharmaceuticals to Present Data on its siRNA Therapeutic Programs in Kidney and Lung Diseases
6. Warner Chilcott Completes Acquisition of P&Gs Global Branded Prescription Pharmaceuticals Business
7. NeoStem Acquires China Biopharmaceuticals Holdings, Inc.; Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company
8. Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
9. China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol NBS
10. Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full-Year Financial Guidance
11. Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... , England , Aug. ... and UK biotechnology company Synairgen plc (LSE: SNG) today announced ... selective inhibitor to the lysyl oxidase type 2 enzyme (LOXL2) ... IPF affects in the region of 100,000 ... global revenues in excess of $1.1 billion by 2017. The LOXL2 ...
(Date:8/4/2015)... On August 3, 2015, a press conference on ... a donation ceremony of a million masks by Wuhan Longfeixiang ... Beijing . Wuhan Longfeixiang ... of Hubei Longfeixiang Industrial Group, which has successfully developed ... Baihe anti-pollution mask, filling the global gap for masks ...
(Date:8/4/2015)... Ill. , Aug. 4, 2015 ... dental supplies and equipment, today announced the acquisition ... Medical Products Laboratories, Inc. ("MPL PDCMD"). MPL PDCMD ... used in preventive and restorative dental procedures. ... expansion of our business in attractive, high-growth segments," ...
Breaking Medicine Technology:Pharmaxis and Synairgen Announce Research Collaboration to Develop LOXL2 Inhibitor For Pulmonary Fibrosis 2Pharmaxis and Synairgen Announce Research Collaboration to Develop LOXL2 Inhibitor For Pulmonary Fibrosis 3Young Innovations Announces Acquisition of Medical Products Laboratories' Professional Dental Contract Manufacturing Division 2
... STOCKHOLM, May 15, 2012 Medivir AB ... infectious diseases, announced today that it has appointed Henric ... commercial activities. Henric, who will have overall responsibility for ... in August 2012 and will be part of the ...
... May 14, 2012 Top leaders representing America,s ... discuss pressing public policy issues affecting job creation and medical ... than $20 billion medical device tax set to begin in ... and Jim Renacci (R-Ohio) joined Walter M Rosebrough, president and ...
Cached Medicine Technology:New Executive Vice President Commercial Appointed 2AdvaMed & BioOhio Discuss MedTech Impact on Ohio's Economy, Job Creation 2AdvaMed & BioOhio Discuss MedTech Impact on Ohio's Economy, Job Creation 3
(Date:8/4/2015)... ... 04, 2015 , ... How cool is it to check in at your ... new "Now" feature will soon allow you to do just that. , Ahhaa is ... using the now feature. , Users will soon get to share what inspires them ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... joined the American Association of Tissue Banks (AATB) as an Affiliate Member. ... “to honor donors, and to save and improve lives by promoting the safety, ...
(Date:8/4/2015)... Boca Raton, FL (PRWEB) , ... August 04, ... ... on-site diagnostic testing organization which provides vascular, electrocardiogram (EKG), echocardiogram, and NCV testing, ... momentum but has been successfully identifying previously undiagnosed cardiovascular abnormalities one program at ...
(Date:8/4/2015)... ... August 04, 2015 , ... Angelina Jolie is in it ... of women every year. Dr. Angela DeRosa, DO, MBA, CPE aka “Dr. ... takes the scary unknown out of menopause. , Myth #1: Menopause only affects ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... scheduled for Nov. 3 – 4, 2015, at UC San Diego, will explore ... businesses, improve food access, and manage resources efficiently against the dueling backdrop of ...
Breaking Medicine News(10 mins):Health News:Ahhaa App Soon to Release the "Now" Feature 2Health News:Exsurco Medical Joins AATB as Affiliate Member 2Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 2Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 3Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 2Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 3Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 2Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 3
... say , WEDNESDAY, Nov. 21 (HealthDay News) -- ... certain sounds, such as the sound of a familiar voice ... Washington, Seattle, and the University of California, Los Angeles, ... activity associated with a given sound task can also identify ...
... vascular disease is widespread and often deadly among older ... treat it, according to a new report by a ... Center and Weill Cornell Medical College campuses of NewYork-Presbyterian ... fact that for years, cardiovascular research has focused almost ...
... Revenues Increase 89% to $3.51 Million versus $1.85 ... Million for Q3 of 2006, -- Third ... ... /Xinhua-PRNewswire-FirstCall/ -- China Yingxia,International, Inc. (OTC Bulletin Board: CYXI), a leading provider in ...
... Eclipsys Corporation(R),(Nasdaq: ECLP ), The Outcomes ... Merrill Lynch Health Services Investor Conference,taking place next ... http://www.newscom.com/cgi-bin/prnh/20050209/FLW006LOGO ), Eclipsys executives will present ... a.m. Eastern time. Interested parties are invited to,listen ...
... 21 Shamir,Optical Industry Ltd. (Nasdaq: SHMR ) ... on Tuesday, November 27, 2007, and has,scheduled a conference ... that,morning., The conference call will be broadcast live ... http://www.kcsa.com approximately five minutes before,the conference call ...
... best value for money, study finds , WEDNESDAY, Nov. 21 ... and programs to improve the quality and value of their ... 21 issue of the Journal of the American Medical ... 609 executives of the largest employers in 41 U.S. ...
Cached Medicine News:Health News:Arterial vascular disease underdiagnosed, undertreated in older US women 2Health News:Arterial vascular disease underdiagnosed, undertreated in older US women 3Health News:Arterial vascular disease underdiagnosed, undertreated in older US women 4Health News:China Yingxia International Announces 2007 Third Quarter Financial Results Conference Call 2Health News:China Yingxia International Announces 2007 Third Quarter Financial Results Conference Call 3Health News:China Yingxia International Announces 2007 Third Quarter Financial Results Conference Call 4Health News:China Yingxia International Announces 2007 Third Quarter Financial Results Conference Call 5Health News:Eclipsys to Present at the Merrill Lynch Health Services Investor Conference 2Health News:Eclipsys to Present at the Merrill Lynch Health Services Investor Conference 3Health News:Shamir Optical Industry Ltd. to Host Conference Call Announcing Third Quarter 2007 Earnings Results 2Health News:Most U.S. Companies Do Little to Boost Worker Health Benefits 2
CleanBox DNA workstation with two 254nm UV lambs & 12-hr timer, 90cm (36-inch)width, single door, 115V (w/crating)...
... tube racks. Its camera-based vision system captures and ... rack, making it ideal for use in automated ... a rack to be read automatically and can ... safety switch prevents a rack from being read ...
... Polypropylene workbench top with powder-coated ... from 25"-34". Available in hundreds ... include shelves, drawers, light fixtures ... an expert in custom building ...
Perforated or Rod Top, Free Standing or Wall Mounted, Storage Cubby Optional, Polypropylene Construction...
Medicine Products: